Today sees a meeting of the All-Party Parliamentary Group on Brain Tumours (APPGBT). This meeting will discuss how the needs of the brain tumour community can be secured as the United Kingdom leaves the European Union.
The APPGBT has a role to play in briefing the brain tumour community on the safeguards needed post-Brexit. These are required to ensure that brain tumour researchers and patients continue to benefit from a relationship with the EU that does not hinder scientific progress or access to drugs and treatments. These safeguards can be summarised as:
- Funds for research – ensuring this is maintained or enhanced
- The health workforce – ensuring there is no loss and that future talent is attracted
- Accessing EU-wide clinical trials – ensuring our patients continue to benefit
- Accessing new brain tumour drugs – ensuring a smooth flow of new drugs to patients in the UK
A summary and minutes of the APPGBT meeting will be uploaded to our APPG page in due course.
Follow us on Twitter for live updates or search the hashtag #APPGBT